{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:53:03Z","timestamp":1781513583149,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA28050"],"award-info":[{"award-number":["AA28050"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA27486"],"award-info":[{"award-number":["AA27486"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA57928"],"award-info":[{"award-number":["DA57928"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["31329"],"award-info":[{"award-number":["31329"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41380-026-03506-6","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:31:32Z","timestamp":1772019092000},"page":"3746-3757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomarker for craving and acamprosate treatment response in patients with alcohol use disorder: insights from multi-omics"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3757-3924","authenticated-orcid":false,"given":"Ming-Fen","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4322-5923","authenticated-orcid":false,"given":"Brandon J.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9350-4440","authenticated-orcid":false,"given":"Joanna M.","family":"Biernacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6843-6503","authenticated-orcid":false,"given":"Paul E.","family":"Croarkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7363-8086","authenticated-orcid":false,"given":"Tyler S.","family":"Oesterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9552-6130","authenticated-orcid":false,"given":"Victor M.","family":"Karpyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-5472","authenticated-orcid":false,"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4911-7985","authenticated-orcid":false,"given":"Richard M.","family":"Weinshilboum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"3506_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax4043","volume":"5","author":"K Witkiewitz","year":"2019","unstructured":"Witkiewitz K, Litten RZ, Leggio L. Advances in the science and treatment of alcohol use disorder. Science Advances. 2019;5:eaax4043.","journal-title":"Science Advances"},{"key":"3506_CR2","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/add.12238","volume":"108","author":"MS Subbaraman","year":"2013","unstructured":"Subbaraman MS, Lendle S, van der Laan M, Kaskutas LA, Ahern J. Cravings as a mediator and moderator of drinking outcomes in the COMBINE study. Addiction. 2013;108:1737\u201344.","journal-title":"Addiction"},{"key":"3506_CR3","doi-asserted-by":"publisher","first-page":"108002","DOI":"10.1016\/j.drugalcdep.2020.108002","volume":"212","author":"M Cavicchioli","year":"2020","unstructured":"Cavicchioli M, Vassena G, Movalli M, Maffei C. Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review. Drug and Alcohol Dependence. 2020;212:108002.","journal-title":"Drug and Alcohol Dependence"},{"key":"3506_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/alcalc\/agy093","volume":"54","author":"ME Stohs","year":"2019","unstructured":"Stohs ME, Schneekloth TD, Geske JR, Biernacka JM, Karpyak VM. Alcohol craving predicts relapse after residential addiction treatment. Alcohol and Alcoholism. 2019;54:167\u201372.","journal-title":"Alcohol and Alcoholism"},{"key":"3506_CR5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","volume":"23","author":"BA Flannery","year":"1999","unstructured":"Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the penn alcohol craving scale. Alcoholism: Clinical and Experimental Research. 1999;23:1289\u201395.","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"3506_CR6","first-page":"108","volume":"23","author":"HR Kranzler","year":"1999","unstructured":"Kranzler HR, Mulgrew CL, Modesto-Lowe V, Burleson JA. Validity of the obsessive compulsive drinking scale (OCDS): does craving predict drinking behavior? Alcohol Clin Exp Res. 1999;23:108\u201314.","journal-title":"Alcohol Clin Exp Res"},{"key":"3506_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.103","volume":"4","author":"VM Karpyak","year":"2014","unstructured":"Karpyak VM, Biernacka JM, Geske JR, Jenkins GD, Cunningham JM, R\u00fcegg J, et al. Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate. Translational Psychiatry. 2014;4:e453.","journal-title":"Translational Psychiatry"},{"key":"3506_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugalcdep.2018.12.010","volume":"196","author":"VM Karpyak","year":"2019","unstructured":"Karpyak VM, Geske JR, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Skime MK, et al. Sex-specific association of depressive disorder and transient emotional states with alcohol consumption in male and female alcoholics. Drug and Alcohol Dependence. 2019;196:31\u20139.","journal-title":"Drug and Alcohol Dependence"},{"key":"3506_CR9","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1038\/s41386-021-01097-0","volume":"46","author":"JM Biernacka","year":"2021","unstructured":"Biernacka JM, Coombes BJ, Batzler A, Ho AM-C, Geske JR, Frank J, et al. Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study. Neuropsychopharmacology. 2021;46:2132\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"3506_CR10","doi-asserted-by":"publisher","first-page":"986238","DOI":"10.3389\/fphar.2022.986238","volume":"13","author":"M-F Ho","year":"2022","unstructured":"Ho M-F, Zhang C, Moon I, Coombes BJ, Biernacka J, Skime M, et al. Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder. Frontiers in Pharmacology. 2022;13:986238.","journal-title":"Frontiers in Pharmacology"},{"key":"3506_CR11","first-page":"16","volume":"173","author":"M-F Ho","year":"2022","unstructured":"Ho M-F, Zhang C, Wei L, Zhang L, Moon I, Geske JR, et al. Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study. British journal of pharmacology. 2022;173:16.","journal-title":"British journal of pharmacology"},{"key":"3506_CR12","doi-asserted-by":"publisher","first-page":"101534","DOI":"10.1016\/j.molmet.2022.101534","volume":"63","author":"MF Ho","year":"2022","unstructured":"Ho MF, Zhang C, Moon I, Wei L, Coombes B, Biernacka J, et al. Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: molecular links between the SNHG16 locus and catecholamine metabolism. Molecular Metabolism. 2022;63:101534.","journal-title":"Molecular Metabolism"},{"key":"3506_CR13","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1038\/s41598-017-02442-4","volume":"7","author":"DJ Hinton","year":"2017","unstructured":"Hinton DJ, V\u00e1zquez MS, Geske JR, Hitschfeld MJ, Ho AMC, Karpyak VM, et al. Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects. Scientific reports. 2017;7:2496.","journal-title":"Scientific reports"},{"key":"3506_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bbi.2024.06.007","volume":"120","author":"M-F Ho","year":"2024","unstructured":"Ho M-F, Zhang C, Cohan JS, Tuncturk M, Heider RM, Coombes BJ, et al. IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study. Brain, Behavior, and Immunity. 2024;120:304\u201314.","journal-title":"Brain, Behavior, and Immunity"},{"key":"3506_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02880-5","volume":"14","author":"M-F Ho","year":"2024","unstructured":"Ho M-F, Zhang C, Moon I, Tuncturk M, Coombes BJ, Biernacka J, et al. Molecular mechanisms involved in alcohol craving, IRF3, and endoplasmic reticulum stress: a multi-omics study. Translational Psychiatry. 2024;14:165.","journal-title":"Translational Psychiatry"},{"key":"3506_CR16","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1038\/s41380-020-0855-9","volume":"26","author":"M-F Ho","year":"2020","unstructured":"Ho M-F, Zhang C, Zhang L, Wei L, Zhou Y, Moon I, et al. TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response. Molecular Psychiatry. 2020;26:3122\u201333.","journal-title":"Molecular Psychiatry"},{"key":"3506_CR17","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1038\/mp.2016.6","volume":"21","author":"M Gupta","year":"2016","unstructured":"Gupta M, Neavin D, Liu D, Biernacka J, Hall-Flavin D, Bobo WV, et al. TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics. Mol Psychiatry. 2016;21:1717\u201325.","journal-title":"Mol Psychiatry"},{"key":"3506_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0056-8","volume":"8","author":"D Liu","year":"2018","unstructured":"Liu D, Ray B, Neavin DR, Zhang J, Athreya AP, Biernacka JM, et al. Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics. Transl Psychiatry. 2018;8:10.","journal-title":"Transl Psychiatry"},{"key":"3506_CR19","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1038\/s41380-020-00940-y","volume":"26","author":"D Liu","year":"2021","unstructured":"Liu D, Zhuang Y, Zhang L, Gao H, Neavin D, Carrillo-Roa T, et al. ERICH3: vesicular association and antidepressant treatment response. Mol Psychiatry. 2021;26:2415\u201328.","journal-title":"Mol Psychiatry"},{"key":"3506_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/clpt.2010.250","volume":"89","author":"Y Ji","year":"2011","unstructured":"Ji Y, Hebbring S, Zhu H, Jenkins GD, Biernacka J, Snyder K, et al. Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram\/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics. Clin Pharmacol Ther. 2011;89:97\u2013104.","journal-title":"Clin Pharmacol Ther"},{"key":"3506_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nature13716","volume":"515","author":"Z Wen","year":"2014","unstructured":"Wen Z, Nguyen HN, Guo Z, Lalli MA, Wang X, Su Y, et al. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature. 2014;515:414\u20138.","journal-title":"Nature"},{"key":"3506_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nprot.2017.152","volume":"13","author":"X Qian","year":"2018","unstructured":"Qian X, Jacob F, Song MM, Nguyen HN, Song H, Ming G-l. Generation of human brain region\u2013specific organoids using a miniaturized spinning bioreactor. Nature Protocols. 2018;13:565.","journal-title":"Nature Protocols"},{"key":"3506_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nature biotechnology. 2015;33:495\u2013502.","journal-title":"Nature biotechnology"},{"key":"3506_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nature biotechnology. 2018;36:411\u201320.","journal-title":"Nature biotechnology"},{"key":"3506_CR25","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;177:1888\u2013e21.","journal-title":"Cell"},{"key":"3506_CR26","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences. 2005;102:15545\u201350.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"3506_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature genetics. 2003;34:267.","journal-title":"Nature genetics"},{"key":"3506_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1677\/joe.1.06019","volume":"186","author":"N Draper","year":"2005","unstructured":"Draper N, Stewart PM. 11\u03b2-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. Journal of Endocrinology. 2005;186:251\u201371.","journal-title":"Journal of Endocrinology"},{"key":"3506_CR29","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, et al. The Genotype-Tissue Expression (GTEx) project. Nature Genetics. 2013;45:580.","journal-title":"Nature Genetics"},{"key":"3506_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.amepre.2019.12.015","volume":"58","author":"MC Lira","year":"2020","unstructured":"Lira MC, Sarda V, Heeren TC, Miller M, Naimi TS. Alcohol policies and motor vehicle crash deaths involving blood alcohol concentrations below 0.08. American journal of preventive medicine. 2020;58:622\u20139.","journal-title":"American journal of preventive medicine"},{"key":"3506_CR31","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0893-133X(02)00368-8","volume":"27","author":"BJ Mason","year":"2002","unstructured":"Mason BJ, Goodman AM, Dixon RM, Hameed MHA, Hulot T, Wesnes K, et al. A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone. Neuropsychopharmacology. 2002;27:596.","journal-title":"Neuropsychopharmacology"},{"key":"3506_CR32","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1213\/ANE.0000000000003481","volume":"127","author":"MP Yeager","year":"2018","unstructured":"Yeager MP, Guyre CA, Sites BD, Collins JE, Pioli PA, Guyre PM. The stress hormone cortisol enhances interferon-\u03c5-mediated proinflammatory responses of human immune cells. Anesth Analg. 2018;127:556\u201363.","journal-title":"Anesth Analg"},{"key":"3506_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0162-3109(89)90042-8","volume":"17","author":"E Sp\u00e4th-Schwalbe","year":"1989","unstructured":"Sp\u00e4th-Schwalbe E, Porzsolt F, Digel W, Born J, Kloss B, Fehm HL. Elevated plasma cortisol levels during interferon-\u03b3 treatment. Immunopharmacology. 1989;17:141\u20135.","journal-title":"Immunopharmacology"},{"key":"3506_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.abrep.2019.100198","volume":"10","author":"EE Hartwell","year":"2019","unstructured":"Hartwell EE, Bujarski S, Green R, Ray LA. Convergence between the penn alcohol craving scale and diagnostic interview for the assessment of alcohol craving. Addictive Behaviors Reports. 2019;10:100198.","journal-title":"Addictive Behaviors Reports"},{"key":"3506_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1530-0277.1995.tb01475.x","volume":"19","author":"RF Anton","year":"1995","unstructured":"Anton RF, Moak DH, Latham P. The obsessive compulsive drinking scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res. 1995;19:92\u20139.","journal-title":"Alcohol Clin Exp Res"},{"key":"3506_CR36","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1046\/j.1360-0443.1998.937109113.x","volume":"93","author":"A Love","year":"1998","unstructured":"Love A, James D, Willner P. A comparison of two alcohol craving questionnaires. Addiction. 1998;93:1091\u2013102.","journal-title":"Addiction"},{"key":"3506_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101798","volume":"77","author":"M-F Ho","year":"2023","unstructured":"Ho M-F, Zhang C, Moon I, Biernacka J, Coombes B, Ngo Q, et al. Epigenetic regulation of GABA catabolism in iPSC-derived neurons: the molecular links between FGF21 and histone methylation. Molecular Metabolism. 2023;77:101798.","journal-title":"Molecular Metabolism"},{"key":"3506_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109753","volume":"243","author":"VM Karpyak","year":"2023","unstructured":"Karpyak VM, Coombes BJ, Geske JR, Pazdernik VM, Schneekloth T, Kolla BP, et al. Genetic predisposition to major depressive disorder differentially impacts alcohol consumption and high-risk drinking situations in men and women with alcohol use disorder. Drug Alcohol Depend. 2023;243:109753.","journal-title":"Drug Alcohol Depend"},{"key":"3506_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2024.100609","volume":"29","author":"TL Verplaetse","year":"2024","unstructured":"Verplaetse TL, Hillmer AT, Bhatt S, Rusowicz A, Li S, Nabulsi N, et al. Imaging a putative marker of brain cortisol regulation in alcohol use disorder. Neurobiol Stress. 2024;29:100609.","journal-title":"Neurobiol Stress"},{"key":"3506_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","volume":"188","author":"Y-T Deng","year":"2025","unstructured":"Deng Y-T, You J, He Y, Zhang Y, Li H-Y, Wu X-R, et al. Atlas of the plasma proteome in health and disease in 53,026 adults. Cell. 2025;188:253\u2013e7.","journal-title":"Cell"},{"key":"3506_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41588-024-02044-7","volume":"57","author":"H Loya","year":"2025","unstructured":"Loya H, Kalantzis G, Cooper F, Palamara PF. A scalable variational inference approach for increased mixed-model association power. Nature Genetics. 2025;57:461\u20138.","journal-title":"Nature Genetics"},{"key":"3506_CR42","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s10038-020-00895-6","volume":"66","author":"AA Crawford","year":"2021","unstructured":"Crawford AA, Bankier S, Altmaier E, Barnes CLK, Clark DW, Ermel R, et al. Variation in the SERPINA6\/SERPINA1 locus alters morning plasma cortisol, hepatic corticosteroid binding globulin expression, gene expression in peripheral tissues, and risk of cardiovascular disease. Journal of Human Genetics. 2021;66:625\u201336.","journal-title":"Journal of Human Genetics"},{"key":"3506_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004474","volume":"10","author":"JL Bolton","year":"2014","unstructured":"Bolton JL, Hayward C, Direk N, Lewis JG, Hammond GL, Hill LA, et al. Genome wide association identifies common variants at the SERPINA6\/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin. PLOS Genetics. 2014;10:e1004474.","journal-title":"PLOS Genetics"},{"key":"3506_CR44","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/hmg\/ddaa038","volume":"29","author":"E Brenner","year":"2020","unstructured":"Brenner E, Tiwari GR, Kapoor M, Liu Y, Brock A, Mayfield RD. Single cell transcriptome profiling of the human alcohol-dependent brain. Human Molecular Genetics. 2020;29:1144\u201353.","journal-title":"Human Molecular Genetics"},{"key":"3506_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0165-5728(86)90037-8","volume":"12","author":"J Roosth","year":"1986","unstructured":"Roosth J, Pollard RB, Brown SL, Meyer WJ. Cortisol stimulation by recombinant interferon-\u03b12. Journal of Neuroimmunology. 1986;12:311\u20136.","journal-title":"Journal of Neuroimmunology"},{"key":"3506_CR46","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/026988110201600307","volume":"16","author":"EM Cassidy","year":"2002","unstructured":"Cassidy EM, Manning D, Byrne S, Bolger E, Murray F, Sharifi N, et al. Acute effects of low-dose interferon-\u03b1 on serum cortisol and plasma interleukin-6. Journal of Psychopharmacology. 2002;16:230\u20134.","journal-title":"Journal of Psychopharmacology"},{"key":"3506_CR47","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1211\/0022357991772529","volume":"51","author":"E Tachikawa","year":"1999","unstructured":"Tachikawa E, Itho K, Kudo K, Harada K, Kashimoto T, Hirota Y. Effects of interferons on cortisol production in bovine adrenal fasciculata cells stimulated by Adrenocorticotropin. Journal of Pharmacy and Pharmacology. 1999;51:465\u201373.","journal-title":"Journal of Pharmacy and Pharmacology"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03506-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:03:04Z","timestamp":1781510584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03506-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3506"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03506-6","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Weinshilboum is a cofounder of and stockholder in OneOme LLC, a pharmacogenomics decision-support company. Dr. Croarkin has received research grant support from Neuronetics, NeoSync and Pfizer, Inc. He has also received grants-in-kind (equipment support for research studies) from Assurex; MagVenture, Inc; and Neuronetics, Inc. Dr. Croarkin has also served on advisory boards for Engrail Therapeutics, Myriad Neuroscience, Procter & Gamble, and Sunovion. All other authors have no conflicts to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}